These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 30942446)
1. TRPC5‑induced autophagy promotes the TMZ‑resistance of glioma cells via the CAMMKβ/AMPKα/mTOR pathway. Zou Y; Chen M; Zhang S; Miao Z; Wang J; Lu X; Zhao X Oncol Rep; 2019 Jun; 41(6):3413-3423. PubMed ID: 30942446 [TBL] [Abstract][Full Text] [Related]
2. TRPC5-induced autophagy promotes drug resistance in breast carcinoma via CaMKKβ/AMPKα/mTOR pathway. Zhang P; Liu X; Li H; Chen Z; Yao X; Jin J; Ma X Sci Rep; 2017 Jun; 7(1):3158. PubMed ID: 28600513 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression. Jiang C; Shen F; Du J; Fang X; Li X; Su J; Wang X; Huang X; Liu Z Biomed Pharmacother; 2018 Jan; 97():844-850. PubMed ID: 29136760 [TBL] [Abstract][Full Text] [Related]
4. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells. Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279 [TBL] [Abstract][Full Text] [Related]
5. The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death. Chen PH; Cheng CH; Shih CM; Ho KH; Lin CW; Lee CC; Liu AJ; Chang CK; Chen KC PLoS One; 2016; 11(11):e0167096. PubMed ID: 27893811 [TBL] [Abstract][Full Text] [Related]
6. The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity. Chen PH; Shen WL; Shih CM; Ho KH; Cheng CH; Lin CW; Lee CC; Liu AJ; Chen KC Neuropharmacology; 2017 Apr; 116():300-314. PubMed ID: 27986595 [TBL] [Abstract][Full Text] [Related]
7. FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K/AKT/mTOR signal pathways. Wu Y; Dong L; Bao S; Wang M; Yun Y; Zhu R Biomed Pharmacother; 2016 Dec; 84():462-469. PubMed ID: 27685789 [TBL] [Abstract][Full Text] [Related]
8. Up-regulation of miR-497 confers resistance to temozolomide in human glioma cells by targeting mTOR/Bcl-2. Zhu D; Tu M; Zeng B; Cai L; Zheng W; Su Z; Yu Z Cancer Med; 2017 Feb; 6(2):452-462. PubMed ID: 28064447 [TBL] [Abstract][Full Text] [Related]
9. Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux. Wen ZP; Zeng WJ; Chen YH; Li H; Wang JY; Cheng Q; Yu J; Zhou HH; Liu ZZ; Xiao J; Chen XP J Exp Clin Cancer Res; 2019 Jul; 38(1):298. PubMed ID: 31291988 [TBL] [Abstract][Full Text] [Related]
10. GSK621 Targets Glioma Cells via Activating AMP-Activated Protein Kinase Signalings. Jiang H; Liu W; Zhan SK; Pan YX; Bian LG; Sun B; Sun QF; Pan SJ PLoS One; 2016; 11(8):e0161017. PubMed ID: 27532105 [TBL] [Abstract][Full Text] [Related]
11. DHFR/TYMS are positive regulators of glioma cell growth and modulate chemo-sensitivity to temozolomide. Zhao M; Tan B; Dai X; Shao Y; He Q; Yang B; Wang J; Weng Q Eur J Pharmacol; 2019 Nov; 863():172665. PubMed ID: 31542479 [TBL] [Abstract][Full Text] [Related]
12. PLK1 inhibitor facilitates the suppressing effect of temozolomide on human brain glioma stem cells. Liu N; Hu G; Wang H; Li Z; Guo Z J Cell Mol Med; 2018 Nov; 22(11):5300-5310. PubMed ID: 30133120 [TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor β agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway. Liu X; Wang L; Chen J; Ling Q; Wang H; Li S; Li L; Yang S; Xia M; Jing L Mol Med Rep; 2015 Feb; 11(2):1516-22. PubMed ID: 25351348 [TBL] [Abstract][Full Text] [Related]
14. Roscovitine effectively enhances antitumor activity of temozolomide in vitro and in vivo mediated by increased autophagy and Caspase-3 dependent apoptosis. Pandey V; Ranjan N; Narne P; Babu PP Sci Rep; 2019 Mar; 9(1):5012. PubMed ID: 30899038 [TBL] [Abstract][Full Text] [Related]
15. LRRC8A potentiates temozolomide sensitivity in glioma cells via activating mitochondria-dependent apoptotic pathway. Yang C; He L; Chen G; Ning Z; Xia Z Hum Cell; 2019 Jan; 32(1):41-50. PubMed ID: 30426452 [TBL] [Abstract][Full Text] [Related]
16. Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide. Johannessen TC; Hasan-Olive MM; Zhu H; Denisova O; Grudic A; Latif MA; Saed H; Varughese JK; Røsland GV; Yang N; Sundstrøm T; Nordal A; Tronstad KJ; Wang J; Lund-Johansen M; Simonsen A; Janji B; Westermarck J; Bjerkvig R; Prestegarden L Int J Cancer; 2019 Apr; 144(7):1735-1745. PubMed ID: 30289977 [TBL] [Abstract][Full Text] [Related]
17. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy. Golden EB; Cho HY; Jahanian A; Hofman FM; Louie SG; Schönthal AH; Chen TC Neurosurg Focus; 2014 Dec; 37(6):E12. PubMed ID: 25434381 [TBL] [Abstract][Full Text] [Related]
18. Oroxylin A reversed Fibronectin-induced glioma insensitivity to Temozolomide by suppressing IP Ding Y; Zhou Y; Li Z; Zhang H; Yang Y; Qin H; Xu Q; Zhao L Life Sci; 2020 Nov; 260():118411. PubMed ID: 32918978 [TBL] [Abstract][Full Text] [Related]
19. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy. Lin CJ; Lee CC; Shih YL; Lin TY; Wang SH; Lin YF; Shih CM Free Radic Biol Med; 2012 Jan; 52(2):377-91. PubMed ID: 22094224 [TBL] [Abstract][Full Text] [Related]
20. β-asarone inhibited cell growth and promoted autophagy via P53/Bcl-2/Bclin-1 and P53/AMPK/mTOR pathways in Human Glioma U251 cells. Wang N; Zhang Q; Luo L; Ning B; Fang Y J Cell Physiol; 2018 Mar; 233(3):2434-2443. PubMed ID: 28776671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]